MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
NAUT — Nautilus Biotechnolgy, Inc. Common Stock
NasdaqNautilus Biotechnolgy, Inc. Common Stock
$1.57
+0.15(+10.56%)
- O
- 1.43
- H
- 1.68
- L
- 1.38
- V
- 8.44M
⏱️ End-of-day dataAs of Oct 1, 2026
Chart
About NAUT
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
IndustryLABORATORY ANALYTICAL INSTRUMENTS
SectorNot available
IPO DateJun 10, 2021
Employees130
Stock ExchangeNasdaq
Ticker SymbolNAUT
Websitehttps://www.nautilus.bio
Key Financial Statistics
| Market Cap | $122.51M |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.62 - $25.89 |
| 52-Week Avg Volume | 301.4K |
| VWAP | $1.56 |
| Transactions | 26,620 |
| Total Recorded Bars | 1,545 days |